Market Capitalization (Millions $) |
273 |
Shares
Outstanding (Millions) |
43 |
Employees |
25 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-22 |
Cash Flow (TTM) (Millions $) |
2 |
Capital Exp. (TTM) (Millions $) |
0 |
Diamedica Therapeutics Inc
Diamedica Therapeutics Inc is a biopharmaceutical company that focuses on the development of innovative therapies for patients with neurological and cardiovascular diseases. The company aims to address unmet medical needs in these areas by leveraging their expertise in protein engineering and biotherapeutics. Their research and development efforts primarily involve the development of drugs that target specific disease mechanisms or pathways. Diamedica Therapeutics Inc is committed to improving patient outcomes and enhancing the quality of life for individuals suffering from these debilitating conditions.
Company Address: 301 Carlson Parkway, Suite 210 Minneapolis 55305 MN
Company Phone Number: 496-5454 Stock Exchange / Ticker: NASDAQ DMAC
|